Skip to main content
Log in


We are pleased to announce that Cellular and Molecular Neurobiology will become a fully open access (OA) on 1 January 2024. As a result, all submissions received from  25 October 2023 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access. 

Cellular and Molecular Neurobiology publishes original research concerned with the analysis of neuronal and brain function at the cellular and subcellular levels. The journal offers timely, peer-reviewed articles that describe anatomic, genetic, physiologic, pharmacologic, and biochemical approaches to the study of neuronal function and the analysis of elementary mechanisms.

This is a transformative journal, you may have access to funding.

  • Juan M. Saavedra
Impact factor
4.0 (2022)
5 year impact factor
4.3 (2022)
Submission to first decision (median)
3 days
454,142 (2022)

Latest articles

Journal updates

  • Cellular and Molecular Neurobiology is transitioning to full open access!

    We are excited to announce that Cellular and Molecular Neurobiology will become a fully open access (OA) journal in 2024. This means that as of January 2024, we will only be publishing open access articles, meaning content will be freely available to readers worldwide, enabling the widest possible dissemination and reuse. 

    Springer Nature is committed to ensuring our portfolios serve and meet the evolving needs of the research community and that quality research is read and disseminated as widely as possible. Transforming Cellular and Molecular Neurobiology to full OA reflects our ongoing commitment to driving the transition to open research, and providing researchers with OA publication venues that can amplify their research and enable compliance with funder and institutional OA requirements, while continuing to deliver a high level of author service. See our FAQs for further information.

  • Transition to fully OA FAQ

    Frequently asked questions regarding the transition to fully open access and what this means for the Cellular and Molecular Neurobiology.

  • Call for Papers: Special Issue: COVID-19 and the Brain

    This is a call for papers for the upcoming special issue "COVID-19 and the Brain", focused on the molecular and cellular mechanisms of COVID-19 in the brain, as well as clinical reports on the prevalence, impact and treatment of brain disorders associated with COVID-19.

Journal information

Electronic ISSN
Print ISSN
Abstracted and indexed in
  2. BFI List
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  8. CNKI
  10. Chemical Abstracts Service (CAS)
  11. Current Contents/ Life Sciences
  12. Dimensions
  13. EBSCO Academic Search
  14. EBSCO Biomedical Reference Collection
  15. EBSCO Discovery Service
  16. EBSCO MasterFILE
  17. EBSCO STM Source
  18. EMBASE
  19. EMBiology
  20. Google Scholar
  21. Japanese Science and Technology Agency (JST)
  22. Journal Citation Reports/Science Edition
  23. Medline
  24. Meta
  25. Naver
  26. OCLC WorldCat Discovery Service
  27. Pathway Studio
  28. Portico
  29. ProQuest-ExLibris Primo
  30. ProQuest-ExLibris Summon
  31. Reaxys
  32. SCImago
  33. SCOPUS
  34. Science Citation Index
  35. Science Citation Index Expanded (SCIE)
  36. TD Net Discovery Service
  37. UGC-CARE List (India)
  38. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature